Skip to content
Screener

Travere Therapeutics, Inc. TVTX Book value per share

Book value per share at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$79.34+19.6%
Jade Biosciences logo
Jade BiosciencesJBIO
$5.13+119%
Vera Therapeutics logo
Vera TherapeuticsVERA
$6.99-16.8%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$0.97+6.7%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$6.31-23.8%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$27.25+26.7%

Other financials

Income statement

See full
Revenue$127.2M+55.6%
Gross profit$125.2M+62.5%
Operating income-$36.9M+13.5%
Net income-$37.1M+10.0%
EPS (diluted)-$0.40+14.9%

Balance sheet

See full
Cash & equivalents$78.4M+26.6%
Total debt$15.6M-82.6%
Total equity$98.7M+201%
Total assets$555.2M+1.2%

Cash flow

See full
Operating cash flow-$40.4M+4.3%
CapEx$140.0K
Free cash flow-$42.5M+28.1%

Valuation

See full
Market cap$5.89B+284%
Enterprise value$5.82B+277%
P/S11×+6.4×

Profitability

See full
Gross margin98.6%+2.6pp
Operating margin-10.6%-5.0pp
Net margin-20.3%-9.5pp
FCF margin-133.9%-34.4pp

Returns & leverage

See full
Return on equity-706%-1,302pp
Debt / equity0.2×-2.6×
Current ratio3.1×+1.1×

Where this comes from

Calculated from Travere Therapeutics, Inc.’s reported figures.

Based on the most recent quarter.

The source filing: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026. Open the filing →

Filed
May 4, 2026, 4:45 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001438533-26-000042

FAQ

What is Travere Therapeutics, Inc.'s book value per share?
Travere Therapeutics, Inc. (TVTX) reported book value per share of $1.07 in Q1 2026.
How has Travere Therapeutics, Inc.'s book value per share changed year-over-year?
Travere Therapeutics, Inc.'s book value per share increased by 189.3% year-over-year, from $0.37 to $1.07.
What is the long-term trend for Travere Therapeutics, Inc.'s book value per share?
Over 5 years (2020 to 2025), Travere Therapeutics, Inc.'s book value per share has grown at a -21.9% compound annual growth rate (CAGR), from $4.44 to $1.29.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.

Ask your AI about Travere Therapeutics, Inc.'s book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude